MRIdian gives clinicians the confidence to shrink margins while escalating dose and reducing fractions. Patients have more treatment options, better treatment outcomes, reduced toxicity and improved quality of life.
Combining the latest innovations in precision radiation delivery, groundbreaking MR image guidance, and on-table adaptive therapy, MRIdian represents a new paradigm in radiation oncology.
ViewRay® to Present at the Jefferies 2020 Virtual Healthcare Conference
ViewRay, Inc. announced today that the Company will present at the Jefferies 2020 Virtual Healthcare Conference. Scott Drake, President and CEO, will participate in a fireside chat at 2:30 p.m. Eastern Time on Tuesday, June 2, 2020.
Providence Portland Medical Center Begins Patient Treatments with ViewRay’s MRIdian Linac
ViewRay, Inc. announced today that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian® MR-Guided Therapy System, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance.
ViewRay, Inc. announced today a strategic collaboration with VieCure, an artificial intelligence (AI) informatics company with a leading point-of-care clinical decision support platform and a comprehensive electronic medical record (EMR) in oncology.
A new kind of medical technology company, ViewRay® Inc. designs, manufactures and markets MRIdian – the world’s first MRI-guided radiation therapy system to image and treat cancer patients simultaneously.
Contact Us Today To Learn More Contact
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy